Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania

Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania
 
 New Center Integrates Traditional Chinese, Romanian and Western Therapies
CAMPINA and PRAHOVA, Romania, July 20 /PRNewswire-Asia/ -- Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com/index.php ), one of the world's leading biotechnology companies focusing on adult stem cell therapies, opened Romania's first rehabilitation center to use traditional Chinese-style rehabilitation techniques in Campina today.

The new Romanian center is Beike's first stand-alone rehabilitation facility in the world. Physical rehabilitation is a key component of Beike's stem cell therapy protocols which are utilized by leading hospitals throughout China. In conjunction with each one-month stem cell treatment cycle, most patients undergo extensive physical therapy and rehabilitation in an effort to enhance the effects of the stem cells. Chinese patients are able to continue with the rehabilitation after the treatment is completed, but often overseas patients can not find affordable therapy when they return home.

The new 240 square-meter center provides traditional Chinese acupuncture, massage, physical therapy, physiotherapy, electrotherapy and medical exercise-based techniques to help patients with neurological and autoimmune diseases such as ataxia, multiple sclerosis, cardiovascular disease, spinal cord injuries and autoimmune disorders, among others.

In addition an important focus for the center is long-term data collection. The center will conduct cooperative studies with local physicians and scientists to determine the efficacy of stem cell treatments with rehabilitation compared to rehabilitation alone.

"We are extremely proud that Beike Biotechnology, the preeminent innovator in stem cell therapies, has chosen our city as home to their first rehabilitation center." noted Beike-Centru De Recuperare Medicala Center Director Gabi Razvan Iordache. A native of Campina, Razvan manages the center with the assistance of Camelia and Cristi Iordache.

Iordache Razvan was first introduced to Beike Biotech when he suffered a spinal cord injury in 1995 from a diving accident. After 11 years of therapy in Romania, Razvan traveled to a leading hospital in China that used Beike stem cells for his first treatment, in 2006. Each of the four times Razvan returned from China, local media focused on his compelling story and the remarkable changes in his abilities that coincided with his journeys. As a result, over the last four years more than 128 people have traveled to China from Romania to receive Beike's stem cell treatments at China's leading hospitals.

Driven by the need to help others, Razvan decided to bring Chinese Medicine treatment protocols to Romania. He said, "During my treatment, I realized not only were the stem cells beneficial to my condition, but the rehab therapy I received during my time in China greatly enhanced my progress. I wanted to bring this advanced rehabilitation to Romania so my fellow countrymen don't have to leave their country to feel better."

Unique in Romania, the new clinic is the only rehabilitation center in the country to offer care integrating traditional Chinese-style medicine with Romanian and Western modalities. The new center is a welcome addition to the city of Campina, according to the city's mayor, Horia Tiseanu. Mr. Tiseanu said, "This medical center is very important for our city. Our citizens now have access to more progressive health care. And, people from all over Romania can travel to Campina to benefit from these modern and efficient treatments."

About Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell therapies are administered by physicians at many leading hospitals throughout China.

Beike's unique processing technologies prepare the cells for use in treating a variety of serious medical conditions including ataxia, brain injury, cerebral palsy, diabetic foot disease, lower limb ischemia, multiple sclerosis, muscular dystrophy, spinal cord injury and optic nerve pathologies.

    For more information, please contact:

    Shenzhen Beike Biotechnology Company, Ltd.
     T. Gutmann
     Shenzhen Hi-Tech Industrial Park
     Tel:   +86-755-8630-9200
     Email: [email protected]
     Web:   http://www.beikebiotech.com

SOURCE Beike Biotechnology Company Limited

 

Suggested Articles

MicuRx nabbed $7.78 million from a nonprofit focused on antimicrobial resistance to push its third antimicrobial program into human trials.

The FDA has handed Scholar Rock a rare pediatric disease designation voucher, which can allow the biotech a speedy review of its SMA med.

The FDA has placed a phase 1/2 trial of Passage Bio’s GM1 gene therapy on clinical hold pending further assessment of the risk of its delivery device.